Tag: Cephalon
US: Ranbaxy pay-for-delay trial starts
As complex as reverse-payment antitrust lawsuits can be, the one being litigated against generic drug maker Ranbaxy over its settlement with Cephalon can be...
2025: Reverse-Payment Settlements Unleashed
Dec 16, 2010
The year is 2025. For the past two decades, brand-name drug companies have settled infringement lawsuits with generic firms by paying them...
